Indexed left atrial volume is superior to left atrial diameter in predicting nonvalvular atrial fibrillation recurrence after successful cardioversion: A prospective study

Echocardiography

Volumn 29, Issue 3, 2012, Pages 276-284

  Marchese, Procolo ^a   Malavasi, Vincenzo ^a   Rossi, Luca ^a   Nikolskaya, Natalia ^a   Donne, Grazia Delle ^a   Becirovic, Mirza ^a   Colantoni, Alessandra ^a   Luciani, Antonio ^a   Modena, Maria Grazia ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

atrial fibrillation; cardioversion; CHA 2DS 2VASc; left atrial remodeling; left atrial volume; recurrence

Indexed keywords

AGED; ARTICLE; BODY SURFACE; CARDIOVERSION; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FUNCTION TEST; HEART LEFT ATRIUM; HUMAN; INDEXED LEFT ATRIAL VOLUME; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RECURRENCE RISK;

AGED; ATRIAL FIBRILLATION; ECHOCARDIOGRAPHY, THREE-DIMENSIONAL; FEMALE; HEART ATRIA; HEART VALVE DISEASES; HUMANS; MALE; ORGAN SIZE; PROGNOSIS; RECURRENCE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 84858794154     PISSN: 07422822     EISSN: 15408175     Source Type: Journal    
DOI: 10.1111/j.1540-8175.2011.01580.x     Document Type: Article

References (35)

1. Bertaglia E, D'Este D, Zerbo F, et al,: Success of serial external electrical cardioversion of persistent atrial fibrillation in maintaining sinus rhythm; a randomized study. Eur Heart J 2002; 23: 1522-1528.
2. Olshansky B, Heller EN, Mitchell LB, et al,: Are transthoracic echocardiographic parameters associated with atrial fibrillation recurrence or stroke? Results from the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study. J Am Coll Cardiol 2005; 45: 2026-2033.
3. Kosior DA, Szulc M, Opolski G, et al,: Long-term sinus rhythm maintenance after cardioversion of persistent atrial fibrillation: Is the treatment's success predictable? Heart Vessels 2006; 21: 375-381.
4. Raitt MH, Volgman AS, Zoble RG, et al,: Prediction of the recurrence of atrial fibrillation after cardioversion in the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study. Am Heart J 2006; 151: 390-396.
5. Parkash R, Green MS, Kerr CR, et al,: The association of left atrial size and occurrence of atrial fibrillation: A prospective cohort study from the Canadian Registry of Atrial Fibrillation. Am Heart J 2004; 148: 649-654.
6. Kerr CR, Humphries KH, Talajic M, et al,: Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: Results from the Canadian Registry of Atrial Fibrillation. Am Heart J 2005; 149: 489-496.
7. Tsang TS, Abhayaratna WP, Barnes ME, et al,: Prediction of cardiovascular outcomes with left atrial size: Is volume superior to area or diameter? J Am Coll Cardiol 2006; 47: 1018-1023.
8. Lang RM, Bierig M, Devereux RB, et al,: Recommendations for chamber quantification. Eur J Echocardiogr 2006; 7: 79-108.
9. Marchese P, Bursi F, Delle Donne G, et al,: Indexed left atrial volume predicts the recurrence of non-valvular atrial fibrillation after successful cardioversion. Eur J Echocardiogr 2011; 12: 214-221.
10. Wang YC, Lin LC, Lin MS, et al,: Identification of good responders to rhythm control of paroxysmal and persistent atrial fibrillation by transthoracic and transesophageal echocardiography. Cardiology 2005; 104: 202-209.
11. Osranek M, Fatema K, Qaddoura F, et al,: Left atrial volume predicts the risk of atrial fibrillation after cardiac surgery: A prospective study. J Am Coll Cardiol 2006; 48: 779-786.
12. Graham I, Atar D, Borch-Johnsen K, et al,: European guidelines on cardiovascular disease prevention in clinical practice: Full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2007; 14 (Suppl 2): S1-S113.
13. Camm AJ, Kirchhof P, Lip GY, et al,: Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 31: 2369-2429.
14. Du Bois D, Du Bois EF,: A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition 1989; 5: 303-311; discussion 12-13.
15. Barbieri A, Bursi F, Zanasi V, et al,: Left atrium reclassified: Application of the American Society of Echocardiography/European Society of Cardiology cutoffs to unselected outpatients referred to the echocardiography laboratory. J Am Soc Echocardiogr 2008; 21: 433-438.
16. Lang RM, Bierig M, Devereux RB, et al,: Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-1463.
17. Amico AF, Lichtenberg GS, Reisner SA, et al,: Superiority of visual versus computerized echocardiographic estimation of radionuclide left ventricular ejection fraction. Am Heart J 1989; 118: 1259-1265.
18. Bonow RO, Carabello BA, Chatterjee K, et al,: Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008; 118: e523-e661.
19. Vahanian A, Baumgartner H, Bax J, et al,: Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007; 28: 230-268.
20. DeLong ER, DeLong DM, Clarke-Pearson DL,: Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics 1988; 44: 837-845.
21. Tsang TS, Barnes ME, Bailey KR, et al,: Left atrial volume: important risk marker of incident atrial fibrillation in 1655 older men and women. Mayo Clin Proc 2001; 76: 467-475.
22. Tsang TS, Barnes ME, Gersh BJ, et al,: Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol 2002; 90: 1284-1289.
23. Tsang TS, Gersh BJ, Appleton CP, et al,: Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. J Am Coll Cardiol 2002; 40: 1636-1644.
24. Vaziri SM, Larson MG, Benjamin EJ, et al,: Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation 1994; 89: 724-730.
25. Psaty BM, Manolio TA, Kuller LH, et al,: Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997; 96: 2455-2461.
26. Abhayaratna WP, Seward JB, Appleton CP, et al,: Left atrial size: Physiologic determinants and clinical applications. J Am Coll Cardiol 2006; 47: 2357-2363.
27. Rodevan O, Bjornerheim R, Ljosland M, et al,: Left atrial volumes assessed by three- and two-dimensional echocardiography compared to MRI estimates. Int J Card Imaging 1999; 15: 397-410.
28. Maddukuri PV, Vieira ML, DeCastro S, et al,: What is the best approach for the assessment of left atrial size? Comparison of various unidimensional and two-dimensional parameters with three-dimensional echocardiographically determined left atrial volume. J Am Soc Echocardiogr 2006; 19: 1026-1032.
29. Casaclang-Verzosa G, Gersh BJ, Tsang TS,: Structural and functional remodeling of the left atrium: Clinical and therapeutic implications for atrial fibrillation. J Am Coll Cardiol 2008; 51: 1-11.
30. Ricard P, Levy S, Trigano J, et al,: Prospective assessment of the minimum energy needed for external electrical cardioversion of atrial fibrillation. Am J Cardiol 1997; 79: 815-816.
31. Wijffels MC, Kirchhof CJ, Dorland R, et al,: Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995; 92: 1954-1968.
32. Lester SJ, Tajik AJ, Nishimura RA, et al,: Unlocking the mysteries of diastolic function: Deciphering the Rosetta Stone 10 years later. J Am Coll Cardiol 2008; 51: 679-689.
33. Connolly SJ, Crijns HJ, Torp-Pedersen C, et al,: Analysis of stroke in ATHENA: A placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter. Circulation 2009; 120: 1174-1180.
34. Kleemann T, Becker T, Strauss M, et al,: Prevalence and clinical impact of left atrial thrombus and dense spontaneous echo contrast in patients with atrial fibrillation and low CHADS2 score. Eur J Echocardiogr 2009; 10: 383-388.
35. McBane RD, Hodge DO, Wysokinski WE,: Clinical and echocardiographic measures governing thromboembolism destination in atrial fibrillation. Thromb Haemost 2008; 99: 951-955.